Secreted by diverse cell types, all three TGF-βisoforms (TGF-β1, TGF-β2, and TGF-β3) are frequently overexpressed in many cancers and correlate with poor prognosis, metastatic spread, and resistance to therapy [20,21]. The gene discussed is TGFB1; the disease is cancer.